Evaluation of oxprenolol hydrochloride permeation through isolated human skin and pharmacodynamic effect in rats

S.T.P. Pharma Sciences

Volumn 8, Issue 3, 1998, Pages 197-201

  Bolgul Y ^a   Hekimoglu S ^a   Sahin Erdemli I ^a   Kas H S ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Human skin; In vitro permeation; Oxprenolol hydrochloride; Pharmacodynamic effect; Transdermal drug delivery system

Indexed keywords

CHITOSAN; OXPRENOLOL;

ARTICLE; CONTROLLED RELEASE FORMULATION; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG ISOLATION; DRUG PENETRATION; DRUG RELEASE; FIRST PASS EFFECT; HUMAN; HUMAN TISSUE; SKIN PERMEABILITY;

EID: 0031774452     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. PARIKH N.H., BABAR A. and PLAKOGIANNIS F.M. - Transdermal therapeutic systems I. - Pharm. Acta Helv., 59, 290-292, 1984.
2. TENJERLA S.N., ALLEN R. and BORAZANI A. - Evaluation of verapamil hydrochloride permeation through human cadaver skin. - Drug Dev. Ind. Pharm., 20, 49-63, 1994.
3. MORIMOTO K., NAGAYASU A., FUKANOKI S., MORISAKA K., HYON S. and IKADA Y. - Evaluation of polyvinyl alcohol hydrogel as sustained-release vehicle for transdermal system of bunitrolol HCI. - Drug Dev. Ind. Pharm., 16, 13-29, 1990.
4. FRIEND D.R. - Transdermal delivery of contraceptives. - Crit. Reviews Ther. Drug Carr. Syst., 7, 149-186, 1990.
5. ROY S.D. and FLYNN G.L. - Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil. - Pharm. Res., 7, 842-847, 1990.
6. SKAUGRUD O. - Chitosan-new biopolymer for cosmetics and drugs. - Drug Cosm. Ind., May, 24-30, 1991.
7. MIYAZAKI S., YAMAGUCHI H., TAKADA M., HOU W., TAKEICHI Y. and YASUBUCHI H. - Pharmaceutical application of biomedical polymers. XXIX: Preliminary study on film dosage form prepared from chitosan for oral drug delivery. - Acta Pharm. Nord., 2, 401-406, 1990.
8. CRUIKSHANK M.J. and PRICHARD B.N.C. - Beta-blockers: Clinical Practice. - Churchill Livingstone, Edinburgh-London-Melbourne-New York, 1987, pp. 177-273.
9. GREEN P.G. and HADGRAFT J. - The use of second-order derivative UV spectroscopy to monitor the percutaneous absorption of naphazoline and oxprenolol. - Int. J. Pharm., 46, 193-198, 1988.
10. BOLGÜL Y., HEKIMOGLUS., KAS H.S., HINCAL A.A. - Chitosan films as vehicle for transdermal delivery of oxprenolol hydrochloride. - Symposium on Transdermal Administration A Case Study, Iontophoresis, 3-4 March 1997, Editions de Santé, Paris.
11. HIRVONEN J., KONTTURI K., MURTAMAKI L., PARONEN P. and URTTI A. - Transdermal iontophoresis of satolol and salicylate; the effect of skin charge and penetration enhancers. - J. Controlled Release, 26, 109-117, 1993.
12. GÜROL Z., HEKIMOGLU S., DEMIRDAMAR R. and SUMNU M. - Percutaneous absorption of ketoprofen. I: In vitro release and percurtaneous absorption of ketoprofen from different ointment bases. - Pharm. Acta Helv., 71, 205-212, 1996.
13. REMUÑAN-LOPEZ C., ALONSO M. J. and BODMEIER R. - Chitosan cross-linked films as vehicles for controlled drug delivery. - 1st World Meeting on Pharmaceutics, Biopharmaceutics, Pharmaceutical Technology, Budapest, 5-11 May 1995, APGI, pp.327-328.
14. REMUÑAN-LOPEZ C. and BODMEIER R. - Mechanical properties and water vapour transmission of polysaccharide films. - 20th International Symposium on Controlled Release of Bioactive Materials, Washington, 25-30 July 1993, Controlled Release Society Inc., pp.364-365.
15. SAETTONE M.F., CHIELLINI G., GIANNACCINI B., CHETONI P. and MONTANARI L. - Release of miconazole from topical PVA matrices: Preliminary in vitro and in vivo data. - J. Cont. Rel., 16, 197-202, 1991.
16. THACHARODI D. and RAO K.P. - Release of nifedipine through crosslinked chitosan membranes. - Int. J. Pharm., 96, 33-39, 1993.
17. ZAKZEWSKI C.A. and LI J. K. - Pulsed mode constant current iontophoretic transdermal metoprolol tartarte delivery in established acute hypertensive rabbits. - J. Controlled Release., 17, 157-162, 1991.
18. KEMKEN J., ZIEGLER A. and MÜLLER B.W. - Investigations into the pharmacodynamic effects of dermally administered microemulsions containing β-blockers. - J. Pharm. Pharmacol., 43, 679-684, 1991.
19. CARGILL R., ENGLE K., RORK G. and CALWELL L.J. - Systemic delivery of timolol after dermal application: transdermal flux and skin irritation potential in the rat and dog. - Pharm. Res., 3, 225-229, 1986.
20. CHOWHAN Z.T., PRITHCHARD R., ROOKS W.H. and TOMOLONIS A. - Effect of surfactants on percutaneous absorption of naproxen. II: In vivo and in vitro correlations in rats. - J. Pharm. Sci., 67, 1645-1647, 1978.
21. FRANZ T.J. - Percutaneous absorption. On the relevance of in vitro data. - The J. Invest. Derm., 64, 190-195, 1975.
22. SHAH H.S., TOJO K. and CHIEN Y.W. - Transdermal controlled delivery of verapamil: determination of in vitro/in vivo relationship. - J. Controlled Release, 22, 133-140, 1992.